McKesson to acquire Emendo

| | Health Imaging | Artificial Intelligence

McKesson has entered a definitive agreement to acquire Emendo, which develops CapPlan Predictive Capacity Planning technology to forecast patient demand and provide clinicians with an enterprise-wide view of activity to make adjustments for patient flow and staffed capacity allocations.

The CapPlan technology represents an extension of the McKesson Enterprise Intelligence and Workforce Management Solutions suites, according to San Francisco-based McKesson, which said that health systems can use capacity management technology to fine-tune staffing requirements, procedure scheduling and resource utilization. Emendo, based in Christchurch, New Zealand, said its CapPlan technology is implemented in more than 40 hospitals throughout New Zealand, Australia, Canada and the U.K. to forecast patient demand and plan resourcing.

Related Content

Experts highlight 'significant concerns' with fluctuating accuracy of popular large language models
FDA clears AI screening tool for cardiac amyloidosis
Are providers too trusting of AI's advice?
Pairing an alert system with CAD software halves time-to-treatment for pneumothorax
Deep learning reconstruction cuts radiation and contrast dose by half in aortic CTA exams
New study highlights the need to include more challenging datasets in AI training

Around the web

Cardiovascular Business
Positron partners with Upbeat Cardiology Solutions to improve cardiac PET/CT access

Positron, a New York-based nuclear imaging company, will now provide Upbeat Cardiology Solutions with advanced PET/CT systems and services. 

Cardiovascular Business
Global shortage of nuclear imaging isotopes may be over

The nuclear imaging isotope shortage of molybdenum-99 may be over now that the sidelined reactor is restarting. ASNC's president says PET and new SPECT technologies helped cardiac imaging labs better weather the storm.

Cardiovascular Business
‘A huge win’: CMS significantly increases Medicare payments for cardiac CT

CMS has more than doubled the CCTA payment rate from $175 to $357.13. The move, expected to have a significant impact on the utilization of cardiac CT, received immediate praise from imaging specialists.